Lorvas SR 1.5 Tablet

Indapamide
1.5mg
Torrent Pharmaceuticals Ltd.
Pack size 100's
Dispensing mode
Source
Agent
Retail Price 12.26 NPR

Available as:

Indications

Lorvas SR 1.5 Tablet is used for: Hypertension, Congestive heart failure

Adult Dose

Oral Hypertension Adult: 1.25-2.5 mg once daily, alone or in conjunction with other antihypertensives. Oedema Adult: 2.5 mg once daily increased to 5 mg daily after 1 wk if needed.

Child Dose

Safety & efficacy not established

Renal Dose

Administration

Should be taken with food.

Contra Indications

Anuria, severe hepatic impairment.

Precautions

Pregnancy, lactation, elderly, renal impairment, fluid or electrolyte imbalance, hyperuricaemia, DM, lupus erythematosus. Lactation: not known if excreted into breast milk, avoid

Pregnancy-Lactation

Interactions

Additive effect with other antihypertensive agents and diuretics. Increased chance of hypokalaemia with corticosteroids, corticotropin and amphotericin. Potentially Fatal: Increased risk of lithium toxicity. Hypokalaemia enhances digitalis toxicity with cardiac gycosides.

Adverse Effects

Side effects of Indapamide : 1-10% Hypotension,Palpation,Flushing,Dizziness,Lightheadedness,Vertigo,Headache,Weakness,Restlessness,Drowsiness,Fatigue,Lethargy,Malaise,Anorexia,Nausea/vomiting,Nocturia,Polyuria,Blurred vision,Rhinnorhea,Electrolyte abnormalities,Pruritus,Rash <1% Cutaneous vasculitis,Glycosuria,Pancreatitis

Mechanism of Action

Indapamide enhances excretion of sodium, chloride and water by interfering with the transport of sodium ions across the renal tubular epithelium.

Note

Lorvas SR 1.5 1.5mg Tablet manufactured by Torrent Pharmaceuticals Ltd.. Its generic name is Indapamide. Lorvas SR 1.5 is availble in Nepal. Farmaco Nepal drug index information on Lorvas SR 1.5 Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.

Some other brands of Indapamide :